These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8762815)

  • 1. Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiency.
    Fuse I; Ootsuka T; Hattori A; Mito M; Shibata A
    Int J Hematol; 1996 Jun; 63(4):317-24. PubMed ID: 8762815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
    Kyrle PA; Eichler HG; Jäger U; Lechner K
    Circulation; 1987 May; 75(5):1025-9. PubMed ID: 3552295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
    Toivanen J; Ylikorkala O; Viinikka L
    Thromb Res; 1985 Feb; 37(4):493-502. PubMed ID: 3920778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
    Preston FE; Greaves M; Jackson CA; Stoddard CJ
    Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
    McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
    Ylikorkala O; Mäkilä UM; Viinikka L
    Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
    De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
    Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
    Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R
    Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic actions of aspirin in the horse.
    Cambridge H; Lees P; Hooke RE; Russell CS
    Equine Vet J; 1991 Mar; 23(2):123-7. PubMed ID: 1904347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
    J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of single-dose aspirin on TXA2 and PGI2 cyclooxygenases in vivo.
    Zaragoza R; Le Breton GC
    Haemostasis; 1987; 17(1-2):40-8. PubMed ID: 3110025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo.
    Wagner B; Eichler HG; Schneider B; Blöchl-Daum B; Brenner B; Gasic S; Lechner K; Kyrle PA
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):453-6. PubMed ID: 1436129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of regular and enteric-coated aspirin on bleeding time, thromboxane, and prostacyclin.
    Gow JA; Ebbeling L; Gerrard JM
    Prostaglandins Leukot Essent Fatty Acids; 1993 Jul; 49(1):515-20. PubMed ID: 8361987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane A2 and prostacyclin release in bleeding time blood during primary haemostasis in healthy individuals.
    Thorngren M; Vinge E
    Acta Med Scand; 1988; 223(2):187-90. PubMed ID: 3279726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.